Furthermore, an imaging technique based on SLC2A2 could also be useful in renal cell carcinoma because SLC2A2 is mainly expressed in liver, absorptive renal cells, and pancreatic β cells [50–52]. Here, SLC2A2 is linked to hereditary clear cell renal cell carcinoma.